Droździk M, Gawrońska-Szklarz B, Wójcicki J
Department of Pharmacology and Toxicology, Pomeranian School of Medicine, Szczecin, Poland.
Acta Pol Pharm. 1994;51(6):517-9.
The study was aimed at the evaluation of changes in phenytoin pharmacokinetics during dietary induced hyperlipidemia in rabbits. It was carried out in 17 New Zealand, male rabbits, 3-month old, randomly assigned to two groups: control maintained on standard diet and experimental one fed on a high-fat diet for 2 months. Pharmacokinetic assays were performed in all animals after 2 months of the experiment. Phenytoin was given intragastrically as a single dose 10 mg/kg. Blood for assays was sampled within 48 hours after phenytoin administration. The two compartment open model for extravascular administration was used for calculations. It was demonstrated that the administration of phenytoin in the group of animals with experimental hyperlipidemia was followed by a decrease of the drug concentration in the blood serum, a drop in area under the plasma concentration-time curve, a shorter elimination half-time as well as an increase in total body clearance. All revealed changes suggest that the dietary induced hyperlipidemic state alters the pharmacokinetics of phenytoin, leading to a faster drug elimination from the body.
该研究旨在评估饮食诱导的家兔高脂血症期间苯妥英药代动力学的变化。实验选用17只3月龄的雄性新西兰家兔,随机分为两组:一组为维持标准饮食的对照组,另一组为喂食高脂饮食2个月的实验组。实验2个月后,对所有动物进行药代动力学测定。苯妥英以10mg/kg的单剂量灌胃给药。在苯妥英给药后48小时内采集血样进行检测。采用血管外给药的二室开放模型进行计算。结果表明,在实验性高脂血症动物组中给予苯妥英后,血清药物浓度降低,血浆浓度-时间曲线下面积下降,消除半衰期缩短,全身清除率增加。所有这些变化表明,饮食诱导的高脂血症状态改变了苯妥英的药代动力学,导致药物从体内更快地消除。